Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report

Intravenous (IV) ketamine and FDA-approved intranasal (IN) esketamine are increasingly used for treatment-resistant depression (TRD). Preliminary studies have suggested a synergistic effect of ketamine and lamotrigine, although the data are inconclusive. Herein, we report the response to serial keta...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Boney, Nunez, Nicolas A., Kung, Simon, Vande Voort, Jennifer L., Pazdernik, Vanessa K., Schak, Kathryn M., Boehm, Stacey M., Carpenter, Brooke, Johnson, Emily K., Malyshev, Grigoriy, Smits, Nathan, Adewunmi, Daniel O., Brown, Sarah K., Singh, Balwinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459873/
https://www.ncbi.nlm.nih.gov/pubmed/37631079
http://dx.doi.org/10.3390/ph16081164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459873/
https://www.ncbi.nlm.nih.gov/pubmed/37631079
http://dx.doi.org/10.3390/ph16081164

Ejemplares similares